Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pranab Ghosh

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Molecular Diversity|July 7, 2023
Molecular iodine catalyzed C(sp2)-H sulfenylation of biologically active enaminone compounds under mechanochemical conditions and studies on their biocidal activity including molecular docking and DFTAminul Islam, Prasun Choudhury, Kaushik Sarkar, et al.
Biometrical Journal. Biometrische Zeitschrift|December 22, 2021
Robust group sequential designs for trials with survival endpoints and delayed responsePranab Ghosh, Robin Ristl, Franz König, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|May 18, 2026
Chiral Amplification in Dynamic Supramolecularly Tailored Aggregates with Enhanced Stimuli-Responsive Fluorescence ActivitySayannita Das, Suraj Mandal, Jiban Sarkar, et al.
Arthritis Care & Research|September 19, 2022
Performance of Modified ALMS and BLISS Criteria with Standard of Care Treatment in Two US Health Care SystemsArezou Khosroshahi, David Tong, Gaobin Bao, et al.
Dermatology and Therapy|May 4, 2026
Automated Measurement of Depigmentation Extent with a New AI Tool Applied to the Example of VitiligoYalei Chen, Tatjana Lukic, All-Shine Chen, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|March 4, 2025
Hierarchical Self-Assembly of J-Aggregated 1,2-Bis(2-(benzyloxy)benzylidene) Hydrazine@2β-Cyclodextrin into Left-Handed Superhelix and Its External Stimuli-Responsive UnwindingSayannita Das, Ankana Karmakar, Suraj Mandal, et al.
RSC Advances|November 20, 2025
Enhancement of catalytic activity using CoFeLDH for the formation of biologically active diaryl sulfide and propargylamine derivatives: molecular docking, DFT, dynamics, and ADMET analyses of their biocidal and anti-diabetic activitiesAminul Islam, Rabindranath Singha, Susanta Kumar Saha, et al.
Journal of the American Academy of Dermatology|December 21, 2024
Response to ritlecitinib with or without narrow-band ultraviolet B add-on therapy in patients with active nonsegmental vitiligo: Results from a phase 2b extension studyYuji Yamaguchi, Elena Peeva, Roni Adiri, et al.
NEJM Evidence|February 9, 2024
Brepocitinib, Zimlovisertib, and Ropsacitinib in Hidradenitis SuppurativaAlexa B Kimball, Elena Peeva, Seth Forman, et al.
Dermatology and Therapy|May 22, 2026
Description of the Tranquillo Phase 3 Clinical Trial Designs/Study Protocols to Assess Ritlecitinib in Adults and Adolescents with Nonsegmental VitiligoTatjana Lukic, Pranab Ghosh, Lynne Napatalung, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Molecular Diversity|July 7, 2023
Molecular iodine catalyzed C(sp2)-H sulfenylation of biologically active enaminone compounds under mechanochemical conditions and studies on their biocidal activity including molecular docking and DFTAminul Islam, Prasun Choudhury, Kaushik Sarkar, et al.
Biometrical Journal. Biometrische Zeitschrift|December 22, 2021
Robust group sequential designs for trials with survival endpoints and delayed responsePranab Ghosh, Robin Ristl, Franz König, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|May 18, 2026
Chiral Amplification in Dynamic Supramolecularly Tailored Aggregates with Enhanced Stimuli-Responsive Fluorescence ActivitySayannita Das, Suraj Mandal, Jiban Sarkar, et al.
Arthritis Care & Research|September 19, 2022
Performance of Modified ALMS and BLISS Criteria with Standard of Care Treatment in Two US Health Care SystemsArezou Khosroshahi, David Tong, Gaobin Bao, et al.
Dermatology and Therapy|May 4, 2026
Automated Measurement of Depigmentation Extent with a New AI Tool Applied to the Example of VitiligoYalei Chen, Tatjana Lukic, All-Shine Chen, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|March 4, 2025
Hierarchical Self-Assembly of J-Aggregated 1,2-Bis(2-(benzyloxy)benzylidene) Hydrazine@2β-Cyclodextrin into Left-Handed Superhelix and Its External Stimuli-Responsive UnwindingSayannita Das, Ankana Karmakar, Suraj Mandal, et al.
RSC Advances|November 20, 2025
Enhancement of catalytic activity using CoFeLDH for the formation of biologically active diaryl sulfide and propargylamine derivatives: molecular docking, DFT, dynamics, and ADMET analyses of their biocidal and anti-diabetic activitiesAminul Islam, Rabindranath Singha, Susanta Kumar Saha, et al.
Journal of the American Academy of Dermatology|December 21, 2024
Response to ritlecitinib with or without narrow-band ultraviolet B add-on therapy in patients with active nonsegmental vitiligo: Results from a phase 2b extension studyYuji Yamaguchi, Elena Peeva, Roni Adiri, et al.
NEJM Evidence|February 9, 2024
Brepocitinib, Zimlovisertib, and Ropsacitinib in Hidradenitis SuppurativaAlexa B Kimball, Elena Peeva, Seth Forman, et al.
Dermatology and Therapy|May 22, 2026
Description of the Tranquillo Phase 3 Clinical Trial Designs/Study Protocols to Assess Ritlecitinib in Adults and Adolescents with Nonsegmental VitiligoTatjana Lukic, Pranab Ghosh, Lynne Napatalung, et al.
Pageof 4